| Typicality: | 0.412 |
| Saliency: | 0.433 |
| for patients | 6 | transitive-object |
| ultimately | 4 | degree |
| for the aspree study participants | 3 | other |
| therapy → improve → outcome | 22 |
| therapy → lead to → better outcomes | 4 |
| therapy → improve → patient outcomes | 3 |
| therapy → be shown to improve → outcome | 3 |
| therapy → improve → clinical outcomes | 3 |
| negative | neutral | positive |
| 0.077 | 0.365 | 0.558 |
| Raw frequency | 35 |
| Normalized frequency | 0.433 |
| Modifier score | 0.700 |
| Perplexity | 97.405 |